Medicure Inc (MPH.V) has shown notable momentum this week, with a significant increase in share price amid recent developments in its clinical research.
Medicure Inc has experienced a positive price action this week, rising by 7.60% over the past five days. The stock closed at C$2.69 on Tuesday, reflecting a 1.13% increase for the day. This uptick is part of a broader trend, with the stock appreciating by 110.16% over the last month and an impressive 135.96% year-to-date. The catalyst for this recent momentum appears to be the presentation of key study data at a prominent medical congress.
Advertisement
Medicure Inc
MPH.V
MPH.V
Medicure Inc
WealthAwesomeMarket cap
$31.10M
52W high
$4.95
52W low
$0.85
1W change
+26.28%
Beta
1.15
Analyst Price Targets
Based on analyst covering MPH · as of Sep 17, 2026
Wall Street analysts forecast MPH stock price to fall 24.3% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.80
-24.3% Upside
Current Price
C$3.70
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MPH's historical volatility
30-Day Vol
125.8%
Annualized
90-Day Vol
135.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$4.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.93 | C$2.54 – C$6.06 |
| 60 trading days | C$4.17 | C$2.26 – C$7.70 |
| 90 trading days | C$4.42 | C$2.09 – C$9.38 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider Medicure's ongoing clinical developments, particularly the Phase 3 study design shared at the European Epilepsy Congress, as potential drivers of future performance. However, the company's negative profit margin and return on equity indicate underlying challenges that need to be monitored closely.
Medicure Inc's stock has surged 110.16% in the last month.
The stock's performance is significantly above its 50-day and 200-day moving averages, indicating strong upward momentum and market interest.
Bull case
The recent presentation of the MEND-PNPO Phase 3 study data could enhance Medicure's credibility in the healthcare sector and attract more investors, especially if the results show promising outcomes.
Bear case
Despite the recent price gains, Medicure's financials, including a negative profit margin and return on equity, raise concerns about its profitability and long-term sustainability. These factors could deter risk-averse investors.
Recent Price Action
Medicure Inc's stock closed at C$2.69 on Tuesday, marking a 1.13% increase for the day. Over the past week, the stock has gained 7.60%, continuing a strong upward trend that has seen it rise 110.16% in the last month and 135.96% year-to-date.
Company News
Advertisement
On September 8, 2026, Medicure presented the design and baseline data from its MEND-PNPO Phase 3 study at the 16th European Epilepsy Congress. This presentation is significant as it highlights the company's ongoing commitment to advancing its clinical trials, which may provide a foundation for future growth and investor interest.
Technical Picture
The technical indicators for Medicure Inc show that the stock is trading well above its 50-day moving average of C$1.62, representing a 65.6% increase. It is also significantly above its 200-day moving average of C$1.27, which is up 111.2% compared to the current price. The stock has a 52-week range of C$0.85 to C$2.74, with the current price sitting at approximately 97% of this range. The beta of 1.27 indicates that the stock is more volatile than the broader market.
Insider Activity
No recent insider activity has been reported for Medicure Inc, which may suggest a stable management perspective amid the company's ongoing developments.
Price Action Summary
Medicure Inc's stock closed at C$2.69, reflecting a daily increase of 1.13%. The stock's strong performance over the past month and year highlights its potential as a growing player in the healthcare sector.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
